Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$212,340,000
+$73,840,000 QoQ
Shares Held
6,000,000
+20.0% QoQ
Ownership
0.831%
of shares outstanding
% of Portfolio
1.95%
of 13F equity value
Holder Rank
#21
of 494 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rubric Capital Management LP holds $1,431,610,576 across 20 Biotechnology names. ROIV ranks #2 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
8,271,577 | $216,880,748 | |
| 2 | ROIV |
Roivant Sciences Ltd.
This page
|
6,000,000 | $212,340,000 | |
| 3 | ZYME |
Zymeworks Inc.
|
7,000,000 | $182,980,000 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
7,227,778 | $175,345,894 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
9,100,000 | $122,941,000 | |
| 6 | ARDX |
Ardelyx, Inc.
|
16,202,700 | $82,633,770 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
9,339,414 | $78,170,895 | |
| 8 | MNKD |
Mannkind Corp
|
18,000,000 | $76,680,000 |
All Filings in ROIV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $212,340,000 | 6,000,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $138,500,000 | 5,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $195,300,000 | 9,000,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $302,600,000 | 20,000,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $229,573,686 | 20,370,336 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $179,269,796 | 17,767,076 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $236,600,000 | 20,000,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $258,496,000 | 22,400,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $243,110,000 | 23,000,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $210,800,000 | 20,000,000 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $213,370,000 | 19,000,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $122,640,000 | 10,500,000 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $35,647,295 | 3,536,438 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $41,328,000 | 5,600,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,970,000 | 3,000,000 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||